Injective's validator lineup is expanding—this time, it's all heavyweight players. Fortune 500 companies and mainstream crypto infrastructure providers are joining one after another, demonstrating that this chain has indeed gained industry trust. And don't forget, the staking return for participating validators exceeds 12% in $INJ, making it a tangible and real opportunity for institutions. With both ecosystem development and economic incentives in place, Injective is attracting more mainstream participants with concrete data.

INJ9.79%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 5
  • Repost
  • Share
Comment
0/400
BlockchainTalkervip
· 2h ago
Actually, let's break this down—12% APY sounds nice on paper, but have we considered the validator set concentration risk here? 🤔 massive institutions dumping capital creates its own set of problems...
Reply0
FlashLoanLordvip
· 2h ago
This lineup really can perform, and a 12% return rate is truly attractive to institutions.
View OriginalReply0
HodlKumamonvip
· 2h ago
12% staking yield? After calculating, it indeed sounds more attractive than many traditional financial products, and the logic for institutional players to enter is valid.
View OriginalReply0
WagmiWarriorvip
· 3h ago
The 12% return is indeed resilient, and institutions are starting to get a whiff of it.
View OriginalReply0
GateUser-3824aa38vip
· 3h ago
12% staking yield? Even institutions can't stay still anymore.
View OriginalReply0
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)